LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.
|
28905880 |
2017 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
|
27564080 |
2016 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
LEUKODYSTROPHY, HYPOMYELINATING, 9
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Nystagmus
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
Variants in RARS1 impair ArgRS activity and do not only lead to a classic hypomyelination presentation with nystagmus and spasticity, but to a wide spectrum, ranging from severe, early-onset epileptic encephalopathy with brain atrophy to mild disease with relatively preserved myelination.
|
31814314 |
2020 |
Nystagmus
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Nystagmus
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Nystagmus, CTCAE 3.0
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Cerebral hypomyelination
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Nystagmus, CTCAE 5.0
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Global developmental delay
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral hypomyelination
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Intellectual Disability
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Nystagmus, CTCAE 5.0
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral atrophy
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Variants in RARS1 impair ArgRS activity and do not only lead to a classic hypomyelination presentation with nystagmus and spasticity, but to a wide spectrum, ranging from severe, early-onset epileptic encephalopathy with brain atrophy to mild disease with relatively preserved myelination.
|
31814314 |
2020 |
Cerebral atrophy
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Ataxia
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |
Seizures
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations in RARS cause hypomyelination.
|
24777941 |
2014 |